Author:
Puglisi F.,Cardellino G.G.,Crivellari D.,Di Loreto C.,Magri M.D.,Minisini A.M.,Mansutti M.,Andreetta C.,Russo S.,Lombardi D.,Perin T.,Damante G.,Veronesi A.
Reference21 articles.
1. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue;Miwa;Eur J Cancer,1998
2. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment;Toi;Lancet Oncol,2005
3. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts;Sawada;Clin Cancer Res,1998
4. Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients;Kurosumi;Oncol Rep,2000
5. Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer;Toi;Br J Cancer,2004
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献